Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide + R-CHOP in Double-expressor DLBCL
NCT03318835Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Aug 2017
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of thalidomide in diffuse large B-cell lymphoma (DLBCL), sponsored by Fudan University. Status: unknown.
02
Drugs
thalidomide
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT03318835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03318835.